Cart
sales@molnova.com
Home - Products - Others - Other Targets - Guacetisal

Guacetisal

CAS No. 55482-89-8

Guacetisal( —— )

Catalog No. M26707 CAS No. 55482-89-8

Guacetisal is extracted from the esterification reaction of acetylsalicylic acid with guaiacol which can be used for research on the treatment of chronic bronchitis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 58 In Stock
5MG 87 In Stock
10MG 159 In Stock
25MG 294 In Stock
50MG 375 In Stock
100MG 528 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Guacetisal
  • Note
    Research use only, not for human use.
  • Brief Description
    Guacetisal is extracted from the esterification reaction of acetylsalicylic acid with guaiacol which can be used for research on the treatment of chronic bronchitis.
  • Description
    Guacetisal is extracted from the esterification reaction of acetylsalicylic acid with guaiacol which can be used for research on the treatment of chronic bronchitis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    LYPLA1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    55482-89-8
  • Formula Weight
    286.283
  • Molecular Formula
    C16H14O5
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (349.31 mM)
  • SMILES
    COc1ccccc1OC(=O)c1ccccc1OC(C)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kok BP, et al. Discovery of small-molecule enzyme activators by activity-based protein profiling. Nat Chem Biol. 2020 Sep;16(9):997-1004.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • glycohyodeoxycholic ...

    glycohyodeoxycholic acid is a major metabolite of the secondary bile acid hyodeoxycholic acid in humans.

  • N-Benzylpalmitamide

    N-benzylpalmitamide inhibits fatty acid amide hydrolase (FAAH) in a time-dependent manner and could potentially offer a good alternative for the treatment of pain, inflammation and CNS degenerative disorders.

  • Asperuloside

    Asperuloside has anti-inflammatory activity.

Sign In Join Free